About AIO-Studien-gGmbH
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
AIO-Studien-gGmbH
3
Clinical Trials at AIO-Studien-gGmbH
During the past decade, AIO-Studien-gGmbH conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate the Effects of Panitumumab if Combined With Chemotherapy for 2nd Treatment of Colorectal Cancer
2009-09-01
2012-03-01
Terminated
9
Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC)
2009-08-01
2015-08-01
Completed
853
ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction
2010-10-01
2017-08-01
Completed
171
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "AIO-Studien-gGmbH"
#1 collaborator was "Amgen" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator, "WiSP Wissenschaftlicher Service Pharma GmbH" with 1 trials as a collaborator and "iOMEDICO AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at AIO-Studien-gGmbH
According to Clinical.Site data, the most researched conditions in "AIO-Studien-gGmbH" are
"Colorectal Neoplasms" (2 trials), "Gastroesophageal Junction Neoplasms" (1 trials) and "Stomach Neoplasms" (1 trials). Many other conditions were trialed in "AIO-Studien-gGmbH" in a lesser frequency.
Clinical Trials Intervention Types at AIO-Studien-gGmbH
Most popular intervention types in "AIO-Studien-gGmbH" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "5-Fluorouracil, Folic acid, Capecitabine; Bevacizumab" (1 trials), "Epirubicin, Cisplatin, Capecitabine" (1 trials), "Epirubicin, Cisplatin, Capecitabine, Panitumumab" (1 trials), "Oxaliplatin, Capecitabine" (1 trials) and "Oxaliplatin, Capecitabine, Panitumumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at AIO-Studien-gGmbH
The vast majority of trials in "AIO-Studien-gGmbH" are
3 trials for "All" genders.
Clinical Trials Status at AIO-Studien-gGmbH
Currently, there are NaN active trials in "AIO-Studien-gGmbH".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in AIO-Studien-gGmbH,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in AIO-Studien-gGmbH, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".